cagrilintide semaglutide combination trial results Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study Cagrilintide–semaglutide (CagriSema) versus semaglutide or
Description
When you switch from a 10mg vial to a 30mg vial, the units-per-dose stay identical
00125-7/asset/25d10da2-038c-4d13-b485-c9856810af68/main.assets/gr3_lrg.jpg)
To replicate proper study conditions, laboratory professionals must handle each peptide vial using aseptic methods and approved laboratory safety practices
Also monitor vitamin levels over time, allowing for adjustments to the injection regimen as needed
Am J Med Sci
